Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to the Maravai Life Sciences Q1 2025 Results Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. You may register to ask a question at any time by pressing star 1 on your telephone keypad. We ask that you please limit yourself to one question and one follow-up. Also, today's call is being recorded, and if you should need any operator assistance during the call today, please press star 0. Now, at this time, I'll turn things over to Ms. Deb Hart, Head of Investor Relations. Please go ahead, ma'am. Good afternoon, everyone. Thanks for joining us for our first quarter 2025 earnings call. Our press release and the slides accompanying today's call are posted on our website and available at investors.moravai.com. As you can see from our agenda for today on slide two, Trey will first provide you with a business update, and Kevin will review our financial results and guidance. Becky Buzio, our Chief Commercial Officer, will join the call for the question and answer session following the prepared remarks. During today's call, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures. It's possible that actual results could differ from management's expectations. We refer you to slide three for more detail on forward-looking statements and our use of non-GAAP financial measures. Our just-issued press release provides reconciliations to the most directly comparable GAAP measures, and we also post reconciling schedules to the IR website. Please also refer to Moravai's SEC filings for additional information on risks and uncertainties that may impact our operating results, performance, and financial condition. Now I'll...